Literature DB >> 22879395

Applicability of the AGREE II instrument in evaluating the development process and quality of current National Academy of Clinical Biochemistry guidelines.

Andrew C Don-Wauchope1, John L Sievenpiper, Stephen A Hill, Alfonso Iorio.   

Abstract

BACKGROUND: Laboratory medicine practice guidelines (LMPGs) are an important part of clinical laboratory medicine. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument has been developed to evaluate the process of practice-guideline development and the quality of reporting. We assessed the applicability of AGREE II in assessing the National Academy of Clinical Biochemistry (NACB) LMPGs.
METHODS: The NACB website was searched for all available LMPGs up to December 2011. Two independent appraisers used the AGREE II instrument to assess each LMPG identified by the search. Quality was assessed across 6 domains (scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence), comprising a total of 23 items and 2 overall assessments, each scored on a 7-point scale (1, strongly disagree, to 7, strongly agree). All scores were expressed as AGREE II calculated percentages (100% indicates that all items scored 7 by all appraisers).
RESULTS: Eleven LMPGs were identified. All of the LMPGs provided some information seen as applicable to clinical practice by the appraisers. Only 5 of the LMPGs had overall scores ≥50%, with a median score of 42% (range: 8%-92%). Individual domain scores varied considerably from 0% to 100%. One guideline achieved a very high score on the instrument.
CONCLUSIONS: The AGREE II instrument is applicable and useful to evaluate LMPGs. All domains were evaluated as being useful to assess LMPGs, some were addressed well (e.g., clarity of presentation), whereas others could be improved (e.g., applicability).
© 2012 American Association for Clinical Chemistry

Entities:  

Mesh:

Year:  2012        PMID: 22879395     DOI: 10.1373/clinchem.2012.185850

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  The Quality of Six Clinical Practice Guidelines in Health and Social Sciences: Are We on the Right Track?

Authors:  Catherine Hébert; Kia Watkins-Martin; Gabrielle Ciquier; Michelle Azzi; Martin Drapeau
Journal:  Adm Policy Ment Health       Date:  2021-04-18

Review 2.  Clinical practice guidelines for the nutritional risk screening and assessment of cancer patients: a systematic quality appraisal using the AGREE II instrument.

Authors:  Hong-Juan Zhou; Li-Jin Deng; Tao Wang; Jin-Xiu Chen; Su-Zhen Jiang; Liu Yang; Fang Liu; Mei-Hua Weng; Jing-Wen Hu; Jing-Yu Tan
Journal:  Support Care Cancer       Date:  2021-02-27       Impact factor: 3.603

Review 3.  Guidelines on vitamin D replacement in bariatric surgery: Identification and systematic appraisal.

Authors:  Marlene Toufic Chakhtoura; Nancy Nakhoul; Elie A Akl; Christos S Mantzoros; Ghada A El Hajj Fuleihan
Journal:  Metabolism       Date:  2016-01-04       Impact factor: 8.694

4.  Defining the Path Forward: Guidance for Laboratory Medicine Guidelines.

Authors:  Stephen E Kahn; Patricia M Jones; Alex C Chin; Robert H Christenson
Journal:  EJIFCC       Date:  2015-08-24

5.  Are Guidelines Guiding us on How to Utilize Laboratory Tests?

Authors:  Andrea R Horvath
Journal:  EJIFCC       Date:  2015-08-24

Review 6.  Appraising of the Clinical Practice Guidelines Quality in the Non-Pharmacological Management of Chemotherapy-Induced Febrile Neutropenia; A Review

Authors:  Shahin Salarvand; Simin Hemati; Payman Adibi; Fariba Taleghani
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26

7.  AGREE-II Appraisal of a clinical algorithm for hypotonia assessment.

Authors:  Pragashnie Govender
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

8.  The quality assessment of intraabdominal infection guidelines/consensuses in 2 decades - which are better and any changes?

Authors:  Yu Wang; Jun Guo; Tingting Xiong; Fangfang Wang; Guoxian Kou; Hong Ning
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.